Sprouty2 and Spred1-2 Proteins Inhibit the Activation of the ERK Pathway Elicited by Cyclopentenone Prostanoids
2011

How Sprouty and Spred Proteins Affect ERK Pathway Activation

publication 10 minutes Evidence: moderate

Author Information

Author(s): García-Domínguez Carlota A., Martínez Natalia, Gragera Teresa, Pérez-Rodríguez Andrea, Retana Diana, León Gonzalo, Sánchez Agustín, Oliva José Luis, Pérez-Sala Dolores, Rojas José M.

Primary Institution: Centro Nacional de Microbiología, Instituto de Salud Carlos III

Hypothesis

Can Sprouty and Spred proteins inhibit ERK activation induced by cyclopentenone prostanoids?

Conclusion

Sprouty2 and Spred proteins negatively regulate the ERK/Elk-1 pathway activation induced by cyclopentenone prostanoids.

Supporting Evidence

  • Ectopic overexpression of Sprouty2 inhibits ERK activation triggered by cyclopentenone prostanoids.
  • The absence of Sprouty2 expression correlates with enhanced ERK activation in certain cell lines.
  • Sprouty2 does not affect K-Ras activation levels induced by cyclopentenone prostanoids.

Takeaway

This study shows that certain proteins can stop a specific signaling pathway in cells that is activated by certain fatty compounds.

Methodology

The study involved overexpressing Sprouty2 and Spred proteins in HeLa cells and measuring ERK activation in response to cyclopentenone prostanoids.

Limitations

The study primarily focuses on in vitro experiments, which may not fully represent in vivo conditions.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0016787

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication